Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

Lapatinib

b5308137-cb6a-54fa-bff3-2c01aa9a4fa2 · FDA Approved · targets EGFR, ERBB2_HER2

Lapatinib

MeasuredReference

Lapatinib targets EGFR, ERBB4_HER4, ERBB2_HER2.

Primary targets

EGFRERBB4_HER4ERBB2_HER2

Top hallmarks

No hallmark data.

Top pathways disrupted

No pathway data.

Resistance landscape — Lapatinib

MeasuredReference

10 known oncogenic variants exist on Lapatinib's top targets — see detail for inhibition impact.

Open in new tab